Psoriatic Arthritis
Advertisement
A study assessed deucravacitinib in patients with active psoriatic arthritis compared with placebo.
Patients with psoriatic arthritis who have enthesitis are more likely to persist on treatment with tofacitinib.
Treatment with guselkumab provided a durable therapeutic benefit to patients with psoriatic arthritis.
Soumya Chakravarty, MD, PhD, FACP, FACR, Senior Director, Strategic Lead, Rheumatology Therapeutic Area at The Janssen ...
In a recent article, investigators described their post hoc analysis of DISCOVER-2, a phase 3 randomized controlled ...
Researchers, led by Gerd R Burmester, conducted a clinical trial to evaluate the long-term safety outcomes of ...
Psoriatic arthritis (PsA) is an inflammatory disease that commonly affects patients with psoriasis. According to a study ...
Ixekizumab demonstrated favorable tolerability and safety, in line with previous reports, for treatment of psoriatic ...
In a recent study, researchers compared ustekinumab versus other biologics and apremilast for risk of serious infection ...
Early identification of certain patient factors may predict long-term outcomes in psoriasis, according to a study. ...
A study retrospectively compared rates of treatment retention with golimumab among patients with rheumatoid arthritis ...
Guselkumab was a safe and effective treatment for biologic-naïve patients with psoriatic arthritis (PsA), according to ...
Patients with psoriatic arthritis (PsA) who achieved minimal disease activity on ixekizumab may relapse if they ...
An analysis of two studies comparing adalimumab biosimilar SDZ-ADL versus reference adalimumab in patient-reported ...
A recent study analyzed the prevalence of and factors associated with sleep disturbances, fatigue, and ...
Inflammatory arthritis (IA) patients often experience fatigue; 41% to 51% of rheumatoid arthritis (RA), psoriatic ...
A study ascertained the effect of joint and skin symptoms on psoriatic arthritis (PsA) patients and found that they ...
Early psoriatic arthritis detection can pose a challenge for rheumatologists—especially in the presence of psoriasis. ...
The randomized, double-blind BE ACTIVE trial compared bimekizumab versus placebo in patients with active psoriatic ...
A new study evaluated healthcare utilization among psoriatic arthritis (PsA) patients in the years leading up to their ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.